Humanized skeletal muscle in MYF5/MYOD/MYF6-null pig embryos

Geunho Maeng; Satyabrata Das; Sarah Greising; Wuming Gong; Bhairab N. Singh; Stefan Kren; Daniel Mickelson; Erik Skie; Ohad Gafni; Jacob R. Sorensen; Cyprian V. Weaver; Daniel J Garry; Mary G. Garry

doi:10.1038/s41551-021-00693-1

Humanized skeletal muscle in MYF5/MYOD/MYF6-null pig embryos

Geunho Maeng, Satyabrata Das, Sarah Greising, Wuming Gong, Bhairab N. Singh, Stefan Kren, Daniel Mickelson, Erik Skie, Ohad Gafni, Jacob R. Sorensen, Cyprian V. Weaver, Daniel J Garry, Mary G. Garry

Research output: Contribution to journal › Article › peer-review

31 Scopus citations

Abstract

Because post-mortem human skeletal muscle is not viable, autologous muscle grafts are typically required in tissue reconstruction after muscle loss due to disease or injury. However, the use of autologous tissue often leads to donor-site morbidity. Here, we show that intraspecies and interspecies chimaeric pig embryos lacking native skeletal muscle can be produced by deleting the MYF5, MYOD and MYF6 genes in the embryos via CRISPR, followed by somatic-cell nuclear transfer and the delivery of exogenous cells (porcine blastomeres or human induced pluripotent stem cells) via blastocyst complementation. The generated intraspecies chimaeras were viable and displayed normal histology, morphology and function. Human:pig chimaeras generated with TP53-null human induced pluripotent stem cells led to higher chimaerism efficiency, with embryos collected at embryonic days 20 and 27 containing humanized muscle, as confirmed by immunohistochemical and molecular analyses. Human:pig chimaeras may facilitate the production of exogenic organs for research and xenotransplantation.

Original language	English (US)
Pages (from-to)	805-814
Number of pages	10
Journal	Nature Biomedical Engineering
Volume	5
Issue number	8
Early online date	Mar 29 2021
DOIs	https://doi.org/10.1038/s41551-021-00693-1
State	Published - Aug 2021

Bibliographical note

Funding Information:
This work was supported by a grant from Regenerative Minnesota Medicine (RMM; D.J.G.) and from the US Department of Defense (M.G.G.). We acknowledge NorthStar Genomics, DeSoto Biosciences, Recombinetics, MOFA Global, the University of Minnesota Genomics Center and the University of Minnesota Imaging Center for their technical assistance. We acknowledge the Cytogenomics Core at the University of Minnesota for karyotyping services. No NIH or RMM funding was used for the human chimaera portions of this study. We thank J. Hannah (Weizmann Institute of Science) for helpful discussions throughout the course of the studies. We also thank R. Prather and the National Swine Resource and Research Center at the University of Missouri for consultation (U42 OD011140).

Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Nature Limited.

Publisher link

10.1038/s41551-021-00693-1

Find It

Find It at U of M Libraries

Cite this

@article{8853b6095263466e9ccc7805866aff5a,

title = "Humanized skeletal muscle in MYF5/MYOD/MYF6-null pig embryos",

abstract = "Because post-mortem human skeletal muscle is not viable, autologous muscle grafts are typically required in tissue reconstruction after muscle loss due to disease or injury. However, the use of autologous tissue often leads to donor-site morbidity. Here, we show that intraspecies and interspecies chimaeric pig embryos lacking native skeletal muscle can be produced by deleting the MYF5, MYOD and MYF6 genes in the embryos via CRISPR, followed by somatic-cell nuclear transfer and the delivery of exogenous cells (porcine blastomeres or human induced pluripotent stem cells) via blastocyst complementation. The generated intraspecies chimaeras were viable and displayed normal histology, morphology and function. Human:pig chimaeras generated with TP53-null human induced pluripotent stem cells led to higher chimaerism efficiency, with embryos collected at embryonic days 20 and 27 containing humanized muscle, as confirmed by immunohistochemical and molecular analyses. Human:pig chimaeras may facilitate the production of exogenic organs for research and xenotransplantation.",

author = "Geunho Maeng and Satyabrata Das and Sarah Greising and Wuming Gong and Singh, {Bhairab N.} and Stefan Kren and Daniel Mickelson and Erik Skie and Ohad Gafni and Sorensen, {Jacob R.} and Weaver, {Cyprian V.} and Garry, {Daniel J} and Garry, {Mary G.}",

note = "Funding Information: This work was supported by a grant from Regenerative Minnesota Medicine (RMM; D.J.G.) and from the US Department of Defense (M.G.G.). We acknowledge NorthStar Genomics, DeSoto Biosciences, Recombinetics, MOFA Global, the University of Minnesota Genomics Center and the University of Minnesota Imaging Center for their technical assistance. We acknowledge the Cytogenomics Core at the University of Minnesota for karyotyping services. No NIH or RMM funding was used for the human chimaera portions of this study. We thank J. Hannah (Weizmann Institute of Science) for helpful discussions throughout the course of the studies. We also thank R. Prather and the National Swine Resource and Research Center at the University of Missouri for consultation (U42 OD011140). Publisher Copyright: {\textcopyright} 2021, The Author(s), under exclusive licence to Springer Nature Limited.",

year = "2021",

month = aug,

doi = "10.1038/s41551-021-00693-1",

language = "English (US)",

volume = "5",

pages = "805--814",

journal = "Nature Biomedical Engineering",

issn = "2157-846X",

publisher = "Nature Publishing Group",

number = "8",

}

TY - JOUR

T1 - Humanized skeletal muscle in MYF5/MYOD/MYF6-null pig embryos

AU - Maeng, Geunho

AU - Das, Satyabrata

AU - Greising, Sarah

AU - Gong, Wuming

AU - Singh, Bhairab N.

AU - Kren, Stefan

AU - Mickelson, Daniel

AU - Skie, Erik

AU - Gafni, Ohad

AU - Sorensen, Jacob R.

AU - Weaver, Cyprian V.

AU - Garry, Daniel J

AU - Garry, Mary G.

N1 - Funding Information: This work was supported by a grant from Regenerative Minnesota Medicine (RMM; D.J.G.) and from the US Department of Defense (M.G.G.). We acknowledge NorthStar Genomics, DeSoto Biosciences, Recombinetics, MOFA Global, the University of Minnesota Genomics Center and the University of Minnesota Imaging Center for their technical assistance. We acknowledge the Cytogenomics Core at the University of Minnesota for karyotyping services. No NIH or RMM funding was used for the human chimaera portions of this study. We thank J. Hannah (Weizmann Institute of Science) for helpful discussions throughout the course of the studies. We also thank R. Prather and the National Swine Resource and Research Center at the University of Missouri for consultation (U42 OD011140). Publisher Copyright: © 2021, The Author(s), under exclusive licence to Springer Nature Limited.

PY - 2021/8

Y1 - 2021/8

N2 - Because post-mortem human skeletal muscle is not viable, autologous muscle grafts are typically required in tissue reconstruction after muscle loss due to disease or injury. However, the use of autologous tissue often leads to donor-site morbidity. Here, we show that intraspecies and interspecies chimaeric pig embryos lacking native skeletal muscle can be produced by deleting the MYF5, MYOD and MYF6 genes in the embryos via CRISPR, followed by somatic-cell nuclear transfer and the delivery of exogenous cells (porcine blastomeres or human induced pluripotent stem cells) via blastocyst complementation. The generated intraspecies chimaeras were viable and displayed normal histology, morphology and function. Human:pig chimaeras generated with TP53-null human induced pluripotent stem cells led to higher chimaerism efficiency, with embryos collected at embryonic days 20 and 27 containing humanized muscle, as confirmed by immunohistochemical and molecular analyses. Human:pig chimaeras may facilitate the production of exogenic organs for research and xenotransplantation.

AB - Because post-mortem human skeletal muscle is not viable, autologous muscle grafts are typically required in tissue reconstruction after muscle loss due to disease or injury. However, the use of autologous tissue often leads to donor-site morbidity. Here, we show that intraspecies and interspecies chimaeric pig embryos lacking native skeletal muscle can be produced by deleting the MYF5, MYOD and MYF6 genes in the embryos via CRISPR, followed by somatic-cell nuclear transfer and the delivery of exogenous cells (porcine blastomeres or human induced pluripotent stem cells) via blastocyst complementation. The generated intraspecies chimaeras were viable and displayed normal histology, morphology and function. Human:pig chimaeras generated with TP53-null human induced pluripotent stem cells led to higher chimaerism efficiency, with embryos collected at embryonic days 20 and 27 containing humanized muscle, as confirmed by immunohistochemical and molecular analyses. Human:pig chimaeras may facilitate the production of exogenic organs for research and xenotransplantation.

UR - http://www.scopus.com/inward/record.url?scp=85103395942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85103395942&partnerID=8YFLogxK

U2 - 10.1038/s41551-021-00693-1

DO - 10.1038/s41551-021-00693-1

M3 - Article

C2 - 33782573

AN - SCOPUS:85103395942

SN - 2157-846X

VL - 5

SP - 805

EP - 814

JO - Nature Biomedical Engineering

JF - Nature Biomedical Engineering

IS - 8

ER -

Humanized skeletal muscle in MYF5/MYOD/MYF6-null pig embryos

Abstract

Bibliographical note

Publisher link

Find It

Other files and links

Fingerprint

University Imaging Centers

Cite this

Humanized skeletal muscle in MYF5/MYOD/MYF6-null pig embryos

Abstract

Bibliographical note

Publisher link

Find It

Other files and links

Fingerprint

University Assets

University Imaging Centers

Cite this